498 related articles for article (PubMed ID: 18647741)
1. Malignant hypertension in HIV-associated glomerulonephritis.
Morales E; Gutierrez-Solis E; Gutierrez E; González R; Martínez MA; Praga M
Nephrol Dial Transplant; 2008 Dec; 23(12):3901-7. PubMed ID: 18647741
[TBL] [Abstract][Full Text] [Related]
2. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
3. [Glomerulopathies associated to HIV infection: a Spanish perspective].
Gutiérrez E; Morales E; Gutiérrez Martínez E; Manzanares MJ; Rosello G; Mérida E; Praga M
Nefrologia; 2007; 27(4):439-47. PubMed ID: 17944581
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated renal disease in London hospitals.
Connolly JO; Weston CE; Hendry BM
QJM; 1995 Sep; 88(9):627-34. PubMed ID: 7583076
[TBL] [Abstract][Full Text] [Related]
5. Glomerular lesions in HIV-infected patients: a Yale University Department of Medicine Residency Peer-Teaching Conference.
Wrone EM; Carey H; Reilly RF
Yale J Biol Med; 1997; 70(2):161-73. PubMed ID: 9493848
[TBL] [Abstract][Full Text] [Related]
6. Kidney diseases in HIV/HCV-co-infected patients.
Izzedine H; Sene D; Cacoub P; Jansen H; Camous L; Brocheriou I; Bourry E; Deray G
AIDS; 2009 Jun; 23(10):1219-26. PubMed ID: 19440143
[TBL] [Abstract][Full Text] [Related]
7. Malignant or accelerated hypertension in IgA nephropathy.
Subías R; Botey A; Darnell A; Montoliu J; Revert L
Clin Nephrol; 1987 Jan; 27(1):1-7. PubMed ID: 3815903
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated kidney glomerular diseases: changes with time and HAART.
Lescure FX; Flateau C; Pacanowski J; Brocheriou I; Rondeau E; Girard PM; Ronco P; Pialoux G; Plaisier E
Nephrol Dial Transplant; 2012 Jun; 27(6):2349-55. PubMed ID: 22248510
[TBL] [Abstract][Full Text] [Related]
9. Malignant hypertension in patients with idiopathic IgA nephropathy.
Chen Y; Tang Z; Yang G; Shen S; Yu Y; Zeng C; Chen H; Liu ZH; Li LS
Kidney Blood Press Res; 2005; 28(4):251-8. PubMed ID: 16340218
[TBL] [Abstract][Full Text] [Related]
10. Observations on a cohort of HIV-infected patients undergoing native renal biopsy.
Berliner AR; Fine DM; Lucas GM; Rahman MH; Racusen LC; Scheel PJ; Atta MG
Am J Nephrol; 2008; 28(3):478-86. PubMed ID: 18176076
[TBL] [Abstract][Full Text] [Related]
11. Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis.
Sevillano ÁM; Cabrera J; Gutiérrez E; Morales E; Mérida E; Huerta A; Cavero T; Hernández E; Moreno JA; Praga M
Nefrologia; 2015; 35(1):42-9. PubMed ID: 25611832
[TBL] [Abstract][Full Text] [Related]
12. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits].
Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380
[TBL] [Abstract][Full Text] [Related]
13. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.
Cao Y; Zhang Y; Wang S; Zou W
Nephrol Dial Transplant; 2009 Sep; 24(9):2745-51. PubMed ID: 19377056
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiology and prognosis in malignant hypertension: comparison by underlying diseases].
Kawazoe N
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):467-76. PubMed ID: 2515135
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy in the treatment of HIV-associated nephropathy.
Atta MG; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Fine DM
Nephrol Dial Transplant; 2006 Oct; 21(10):2809-13. PubMed ID: 16864598
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variants in the chromogranin a promoter are associated with renal injury in IgA nephropathy patients with malignant hypertension.
Yu L; Jiang L; Zhou XJ; Zhu L; Zhang H
Ren Fail; 2010 Jan; 32(1):41-6. PubMed ID: 20113265
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognosis of malignant hypertension; difference between underlying diseases such as essential hypertension and chronic glomerulonephritis.
Kawazoe N; Eto T; Abe I; Takishita S; Ueno M; Kobayashi K; Uezono K; Muratani H; Kimura Y; Tomita Y
Clin Nephrol; 1988 Feb; 29(2):53-7. PubMed ID: 3359695
[TBL] [Abstract][Full Text] [Related]
18. [Malignant hypertension presenting with renal damage: a clinical and pathological analyses].
Zhou F; Liu Y; Zou W; Zhang Y; Wang H
Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):165-8. PubMed ID: 11798572
[TBL] [Abstract][Full Text] [Related]
19. Malignant arterial hypertension. Relationship between blood pressure control and renal function during long-term observation of patients with malignant nephrosclerosis.
Jespersen B; Eiskjaer H; Christiansen NO; Olsen S; Pedersen EB
J Clin Hypertens; 1987 Dec; 3(4):409-18. PubMed ID: 3453383
[TBL] [Abstract][Full Text] [Related]
20. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
